20 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-10-20 21:31 UTC
Stride reported first-quarter revenue of $639.4 million, up 3% year over year, while enrollment came in below expectations amid technology-platform issues affecting applications and new-student retention. The company forecast full-year revenue of $2.53 billion to $2.61 billion and adjusted operating income of $500 mill
News 2026-10-12 11:25 UTC
On Thursday, Cytokinetics (NASDAQ: CYTK ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Cytokinetics reported strong commercial momentum for Myc
News 2026-10-08 10:47 UTC
Galaxy Digital (NASDAQ: GLXY ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and transcripts, visit Access the full call at Summary Galaxy Digital reported a GAAP net loss of $85 mill
News 2026-10-08 10:47 UTC
Galaxy Digital Hldgs (TSX: GLXY ) reported second-quarter financial results on Wednesday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Full Transcript OPERATOR Goo
News 2026-10-07 20:59 UTC
Bitcoin fell 3% to $83,098 and ethereum lost 5% to $2,564 as traders pointed to record-high Treasury yields and a stronger U.S. dollar. XRP and solana also declined in a broader crypto selloff.
News 2026-10-07 11:42 UTC
The latest Market Talks covering Equities. Published exclusively on Dow Jones Newswires throughout the day. 1142 GMT - Burberry should continue to benefit from its strategic turnaround, but it isn't insulated from the broader sector context, AlphaValue's Jie Zhang says in a note. The British luxury group has showed enc
News 2026-10-07 09:35 UTC
Citi analysts view Informa's strategic plan to separate its academic markets business, Taylor & Francis, and acquire Clarion Events as a positive move that should create a higher growth business benefiting from structural tailwinds.
News 2026-10-06 09:41 UTC
Reuters listed M&A bids and deals reported by 0930 GMT Tuesday, including BPCE’s 7% Sabadell stake purchase, Informa’s £2.24 billion bid for Clarion, and KKR’s $5.1 billion deal for Gen II Fund Services, plus other transactions.
News 2026-10-06 08:00 UTC
Iovance Biotherapeutics (NASDAQ: IOVA ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. Access the full call
News 2026-10-06 06:30 UTC
Oct 6 (Reuters) — Informa PLC: Informa Plc - Growth, Focus & International Expansion Informa - Announces Plans To Separate Taylor & Francis Informa - To Buy Clarion In £2.24 Billion Deal Informa - Identifies £50 Million Annual Run Rate Operating Synergies Informa - Acquisition Expected To Enhance Adjusted Diluted Eps I
News 2026-10-06 06:05 UTC
Informa announced plans to separate its Academic Markets business, which includes Taylor & Francis.
News 2026-10-05 13:05 UTC
Immunocore Hldgs (NASDAQ: IMCR ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Immunocore H
News 2026-10-05 11:46 UTC
Insmed (NASDAQ: INSM ) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. APIs provide real-time access to earnings call transcripts and financial data. Visit to learn more. Access the full call at Summary Insmed reported strong
News 2026-09-29 06:03 UTC
The specialist dermatology and oncology company said it achieved first revenues from skin+CELL direct-to-consumer sales and completed a strategic acquisition of Swiss skincare brand énielle. It also said it raised gross proceeds of £355,000 through unsecured convertible loan notes.
News 2026-09-28 12:08 UTC
Worldsec Limited reported an unaudited net loss of US$490,000 for the six months ended 30 June 2026, versus a loss of US$97,000 a year earlier. The company also said it appointed Elemental Company Secretary Limited as company secretary in September 2026.
News 2026-09-21 08:40 UTC
Prenetics Global (NASDAQ: PRE ) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is ava
News 2026-09-18 08:37 UTC
On Thursday, Illumina (NASDAQ: ILMN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Illumina reported strong Q2 2026 performance with revenue gr
News 2026-09-09 21:39 UTC
Research Solutions said fiscal 2026 revenue was $48.3 million, down from $49.1 million in fiscal 2025. Platform subscription revenue rose 10% to $20.8 million, and the company said it booked about $800,000 in AI-related orders in Q4.
News 2026-09-08 18:46 UTC
Most investors divide the market into neat boxes. Growth investors want expanding companies. Income investors want dependable dividends. Small-cap investors want undiscovered businesses that can become much larger. Some of the market’s most interesting stocks sit at the intersection of all three categories. These small
News 2026-09-03 14:55 UTC
John Wiley & Sons said Q1 Research publishing revenue rose 12%, while Learning revenue fell 20%. The company reiterated full-year guidance for mid-single-digit organic revenue growth, adjusted EPS of $4.60 to $5.05 and free cash flow of $205 million.